Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The NSG-hIL6 Mouse As a Novel Murine Patient Derived Xenograft Model of Plasma Cell Dyscrasias for Study of Disease Biology and Therapeutic Development

Zainul Hasanali, Alfred L. Garfall, Martin P. Carroll, Anthony Secreto, Nicolas Skuli, Carly Roman, Leonard Shultz, Neil Sheppard, Edward A. Stadtmauer, David Allman

Blood (2022) 140 (Supplement 1): 9921–9922.

https://doi.org/10.1182/blood-2022-167751

Published: 2022

Journal Articles

Combined Epigenetic and Immunotherapy For Newly Diagnosed Mantle Cell Lymphoma: Correlative Studies Suggest The Importance Of Enhanced ADCC, Mechanisms of Resistance and Cyclin D1 Nuclear Localization Genotype

Kamal Sharma, DO, Violetta V. Leshchenko, PhD, Zainul Hasanali, BS, August Stuart, MS, Sara Shimko, BS, Stephen E Spurgeon, MD, Samir Parekh, MD, Elliot M Epner, MD Phd

Blood (2013) 122 (21): 3063.

https://doi.org/10.1182/blood.V122.21.3063.3063

Published: 2013

Journal Articles

Epigenetic Modulation of CD30 Gene Expression in Alemtuzumab Resistant T Cell Malignancy:Rationale and Efficacy of Brentuximab Vedotin.

Zainul Hasanali, BS, Kamal Sharma, DO, Sara Shimko, BS, August Stuart, BA, Elliot M Epner, MD, PhD

Blood (2012) 120 (21): 2454.

https://doi.org/10.1182/blood.V120.21.2454.2454

Published: 2012

Journal Articles

Establishment of a New Mantle Cell Lymphoma Cell Line That Has Epigenetically Silenced CD20 As a Resistance Mechanism in Vivo

August Stuart, BA, Kamal Sharma, DO, Sara Shimko, BS, Zainul Hasanali, BS, Elliot M Epner, MD, PhD

Blood (2012) 120 (21): 4619.

https://doi.org/10.1182/blood.V120.21.4619.4619

Published: 2012

Journal Articles

Epigenetic Modulation of Alemtuzumab Mediated Antileukemia Effects and Resistance in T- Cell Prolymphocytic Leukemia

Kamal Sharma, DO, Mithun Shah, MD, PhD, Zainul Hasanali, BA, Vikas Ghai, MD, Katie Broeg, BS, Sara Shimko, BS, August Stuart, BA, Elliot M Epner, MD, PhD, Thomas P. Loughran, Jr., M.D.

Blood (2011) 118 (21): 2440.

https://doi.org/10.1182/blood.V118.21.2440.2440

Published: 2011

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The NSG-hIL6 Mouse As a Novel Murine Patient Derived Xenograft Model of Plasma Cell Dyscrasias for Study of Disease Biology and Therapeutic Development

Combined Epigenetic and Immunotherapy For Newly Diagnosed Mantle Cell Lymphoma: Correlative Studies Suggest The Importance Of Enhanced ADCC, Mechanisms of Resistance and Cyclin D1 Nuclear Localization Genotype

Epigenetic Modulation of CD30 Gene Expression in Alemtuzumab Resistant T Cell Malignancy:Rationale and Efficacy of Brentuximab Vedotin.

Establishment of a New Mantle Cell Lymphoma Cell Line That Has Epigenetically Silenced CD20 As a Resistance Mechanism in Vivo

Epigenetic Modulation of Alemtuzumab Mediated Antileukemia Effects and Resistance in T- Cell Prolymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

The NSG-hIL6 Mouse As a Novel Murine Patient Derived Xenograft Model of Plasma Cell Dyscrasias for Study of Disease Biology and Therapeutic Development

Combined Epigenetic and Immunotherapy For Newly Diagnosed Mantle Cell Lymphoma: Correlative Studies Suggest The Importance Of Enhanced ADCC, Mechanisms of Resistance and Cyclin D1 Nuclear Localization Genotype

Epigenetic Modulation of CD30 Gene Expression in Alemtuzumab Resistant T Cell Malignancy:Rationale and Efficacy of Brentuximab Vedotin.

Establishment of a New Mantle Cell Lymphoma Cell Line That Has Epigenetically Silenced CD20 As a Resistance Mechanism in Vivo

Epigenetic Modulation of Alemtuzumab Mediated Antileukemia Effects and Resistance in T- Cell Prolymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only